Search Within

Department of Medicine

Formats
  1. Journal Article (19613)
  2. Meeting Abstract (16046)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22344)
  2. Hematologic Malignancies, Division of (13286)
  3. Center for Hematologic Malignancies (11069)
  4. GSK Faculty (10650)
  5. Survivorship Research (9343)
  6. Division of Subspecialty Medicine (7553)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1112)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2290)
  6. Nature Publishing Group (2119)

More Publishers

Results (39663)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized study of mixed bacterial vaccine (MBV) for follicular lymphoma (FL): An evaluation over 20 years
    Meeting Abstract

    Kempin, S.; Straus, D. J.; Koziner, B.; Lee, B. J.; Mertelsmann, R. H.; Nisce, L.; Camacho, E.; Filippa, D.; Old, L.; Arlin, Z.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • Phase II clinical experience with the proteasome inhibitor PS-341 in patients with indolent lymphomas
    Meeting Abstract

    O'Connor, O. A.; Moskowitz, C. H.; Wright, J. J.; Macgregor-Cortelli, B.; Straus, D.; Furst, D.; Horse-Grant, D.; Schenkein, D. P.; Zelenetz, A. D.
    Blood (2002)

    Fulltext@MSK | Save
  • Clone specific PCR detects clonal cells after radiation therapy for early stage gastric MALT lymphoma
    Meeting Abstract

    Noy, A.; Yahalom, J.; Zaretsky, L.; Brett, I.; Zelenetz, A. D.
    Blood (2002)

    Fulltext@MSK | Save
  • LPAM (Alpha4 Beta7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease but not graft-versus-tumor effect
    Meeting Abstract

    Kirovski, A.; Feinman, J. W.; Alpdogan, O.; Willis, L. M.; Eng, J.; Kartono, T. H.; van den Brink, M. R. M.
    Blood (2002)

    Fulltext@MSK | Save
  • An analysis of accelerated full course chemotherapy followed by upfront high dose therapy (HDT) and autologous stem cell transplantation (ASCT) for patients with International Prognostic Index IV (IPI IV) aggressive NHL
    Meeting Abstract

    Moskowitz, C. H.; Kewalramani, T.; Donnelly, G.; Zelenetz, A. D.; Noy, A.; Rice, D.; Kuznetsov, M.; Straus, D.; Nimer, S. D.; Portlock, C. S.
    Blood (2002)

    Fulltext@MSK | Save
  • Similar outcomes for chemosensitive (CS) relapsed or primary refractory peripheral T-cell lymphoma (PTCL) and diffuse large B-cell lymphoma (DLBCL) treated with autologous transplantation (ASCT)
    Meeting Abstract

    Kewalramani, T.; Nimer, S. D.; Zelenetz, A. D.; Hamlin, P. A.; Horwitz, S.; Qin, J.; Malhotra, S.; Yahalom, J.; Moskowitz, C. H.
    Blood (2002)

    Fulltext@MSK | Save
  • High-resolution DNA typing for HLA-A, -B, and -DRB1 has direct impact on the survival in the recipients of unrelated donor (URD) hematopoietic stem cell transplant (HSCT)
    Meeting Abstract

    Prasad, V.; Kernan, N. A.; Heller, G.; Boulad, F.; Castro-Malaspina, H.; Jakubowski, A.; Papadopoulos, E.; Perales, M.; Small, T. N.; Van Den Brink, M.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • Intravenous busulfan and melphalan followed by an unmodified related or unrelated hematopoietic stem cell transplant for the treatment of advanced hematologic malignancies
    Meeting Abstract

    Papadopoulos, E. B.; Boulad, F.; Castro-Malaspina, H.; Jakubowski, A. A.; Kernan, N. A.; Perales, M. A.; Prasad, V.; Young, J. W.; Van Den Brink, M.; Toomasi, F.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • Gemicitabine/vinorelbine - A well tolerated and effective regimen for patients with relapsed/refractory Hodgkin's disease (RD) who fail autologous stem cell transplantation (ASCT)
    Meeting Abstract

    Hamlin, P. A.; Kewalramani, T.; Schaindlin, P.; Moskowitz, C. H.
    Blood (2002)

    Fulltext@MSK | Save
  • Ig V-H and V-L patient-specific PCR: Assessing clonotypic contamination in stem cell components (SCC) mobilized with melphalan in myeloma
    Meeting Abstract

    Zhou, P.; Zhang, Y.; Martinez, C.; Kalakonda, N.; Nimer, S. D.; Comenzo, R. L.
    Blood (2002)

    Fulltext@MSK | Save